SCHEMBL598786

SCHEMBL598786

CC1[C@H](C)CCC[C@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6130371 1.00
SCHEMBL598785 1.00
SCHEMBL28899616 1.00
SCHEMBL451346 1.00
SCHEMBL597259 1.00
SCHEMBL10582987 0.92 CA1 (0.42)
SCHEMBL10579627 0.92 CA1 (0.50)
SCHEMBL28091637 0.88 CA1 (0.47)
SCHEMBL23520599 0.82
SCHEMBL8383241 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117953990-A Integrated calculation method for constructing high-resolution mass spectrum library of atmospheric organic pollutants based on low-resolution mass spectrum library 大连理工大学 2024-04-30 CN disclosed
US-20120202766-A1 N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS PHARMASSET, INC. (US) 2012-08-09 US disclosed
US-8114997-B2 N4-acylcytosine nucleosides for treatment of viral infections PHARMASSET, INC. (US) 2012-02-14 US disclosed
US-RE42015-E1 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections PHARMASSET, INC. (US) 2010-12-28 US disclosed
US-20090176730-A1 N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS PHARMASSET, INC. (US) 2009-07-09 US disclosed
EP-1569652-A4 N SP 4 /SP-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL IINFECTIONS PHARMASSET INC (US) 2008-07-02 EP disclosed
EP-1480982-A4 MODIFIED FLUORINATED NUCLEOSIDE ANALOGUES PHARMASSET INC (US) 2007-08-01 EP disclosed
US-20070078080-A1 N4-Acylcytosine Nucleosides for Treatment of Viral Infections GILEAD PHARMASSET LLC 2007-04-05 US disclosed
US-7105527-B2 N4-acylcytosine nucleosides for treatment of viral infections GILEAD PHARMASSET LLC 2006-09-12 US disclosed
EP-1569652-A2 N SP 4 /SP-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL IINFECTIONS Pharmasset Ltd. (BB) 2005-09-07 EP disclosed
EP-1480982-A2 MODIFIED FLUORINATED NUCLEOSIDE ANALOGUES Pharmasset Ltd. (BB) 2004-12-01 EP disclosed
US-20040214844-A1 N4-acylcytosine nucleosides for treatment of viral infections GILEAD PHARMASSET LLC 2004-10-28 US disclosed
EP-1409614-A1 CONTINUOUS PROCESS FOR OXIDATIVE DESULFURIZATION OF FOSSIL FUELS WITH ULTRASOUND AND PRODUCTS THEREOF Sulphco, Inc. (US) 2004-04-21 EP disclosed
US-20040002476-A1 Modified fluorinated nucleoside analogues PHARMASSET, LTD. (BB) 2004-01-01 US disclosed
US-20030176319-A1 For therapy and prophylaxis of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections, in human patients or other animal hosts GILEAD PHARMASSET LLC 2003-09-18 US disclosed
US-20030162992-A1 Reacting a 2,2-dialkoxyethyl halide with an appropriate carboxylate compound to obtain acetal compound; hydrolyzing the acetal to form the alpha -acyloxyacetaldehyde PHARMASSET, INC. 2003-08-28 US disclosed
WO-2003068162-A2 MODIFIED FLUORINATED NUCLEOSIDE ANALOGUES PHARMASSET LTD. (BB) 2003-08-21 WO disclosed
WO-2003063771-A2 N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL IINFECTIONS PHARMASSET LTD. (BB) 2003-08-07 WO disclosed
US-6500219-B1 COMBINING SULFIDE-CONTAINING DIESEL FUEL HAVING CETANE INDEX OF GREATER THAN 50.0 WITH AQUEOUS FLUID AND HYDROPEROXIDE AND ALIPHATIC C15-C20 HYDROCARBON, USING ULTRASOUND TO CAUSE OXIDATION OF SULFIDES SULPHCO, INC. 2002-12-31 US disclosed
WO-2002074884-A1 CONTINUOUS PROCESS FOR OXIDATIVE DESULFURIZATION OF FOSSIL FUELS WITH ULTRASOUND AND PRODUCTS THEREOF SULPHCO, INC. (US) 2002-09-26 WO disclosed